Therapeutic area

Musculoskeletal and connective tissue disorders – page 65

863 clinical trials
359 recruiting
328 conditions
28 countries

Clinical trials in Musculoskeletal and connective tissue disorders

863 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

863 clinical trials

Dry eye+1

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Ianalumab
Sponsor:Novartis Pharma AG

Contact Research Centre

Glycogen storage disease type II

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Avalglucosidase Alfa for Babies with Infantile-Onset Pompe Disease

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Avalglucosidase Alfa
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Duchenne muscular dystrophy

Not recruiting

Investigational

Study of DYNE-251 safety and effectiveness in patients with Duchenne muscular dystrophy who are candidates for exon 51 skipping treatment

Investigational

Belgium

Participants:0–17 years
Substances:Fragment Antibody Targeting Human Tfr1 Conjugated To Phosphorodiamidate Morpholino Oligomer
Sponsor:Dyne Therapeutics Inc.

Contact Research Centre

Dry eye+1

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Ianalumab
Sponsor:Novartis Pharma AG

Contact Research Centre

Gouty arthritis+1

Not recruiting

Registered drugNo placebo

Study on Gout Treatment: Comparing Allopurinol, Benzbromarone, and Febuxostat in Patients with Gout in Remission

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Allopurinol
Sponsor:Sint Maartenskliniek

Contact Research Centre

Spinal muscular atrophy

Not recruiting

Investigational

Study of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History

Investigational

Belgium

Participants:0–17 years · 18–64 years
Substances:Taldefgrobep Alfa
Sponsor:Biohaven Pharmaceuticals Inc.

Contact Research Centre

Osteoarthritis

Not recruiting

Registered drug

Study on Improving Knee Implant Stability in Osteoarthritis Patients Using Denosumab and Zoledronic Acid

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Denosumab
Sponsor:Region Midtjylland

Contact Research Centre

Duchenne muscular dystrophy

Not recruiting

Registered drug

Study on the Effects of Fordadistrogene Movaparvovec for Patients with Duchenne Muscular Dystrophy

Registered drug

Belgium

Participants:0–17 years
Substances:Eculizumab
Sponsor:Pfizer Inc.

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drugNo placebo

Study on the Long-Term Safety and Effectiveness of Filgotinib for Patients with Rheumatoid Arthritis

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Filgotinib
Sponsor:Alfasigma S.p.A.

Contact Research Centre

Psoriatic arthropathy

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bimekizumab
Sponsor:UCB Biopharma

Contact Research Centre

Glycogen storage disease type II

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cipaglucosidase Alfa
Sponsor:Amicus Therapeutics Inc.

Contact Research Centre

Myasthenia gravis

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Zilucoplan Sodium
Sponsor:UCB Biopharma

Contact Research Centre

Substances studied in this area

The therapies tested most often in Musculoskeletal and connective tissue disorders trials.

Sodium Chloride47 clinical trials Paracetamol32 clinical trials Tocilizumab29 clinical trials Methotrexate25 clinical trials Adalimumab23 clinical trials Rituximab23 clinical trials Cyclophosphamide20 clinical trials Etanercept19 clinical trials Baricitinib17 clinical trials

Musculoskeletal and connective tissue disorders – page 65

Conditions in this area

Clinical trials in Musculoskeletal and connective tissue disorders

863 clinical trials

Dry eye+1

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Glycogen storage disease type II

Study on the Effectiveness and Safety of Avalglucosidase Alfa for Babies with Infantile-Onset Pompe Disease

Duchenne muscular dystrophy

Study of DYNE-251 safety and effectiveness in patients with Duchenne muscular dystrophy who are candidates for exon 51 skipping treatment

Dry eye+1

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Gouty arthritis+1

Study on Gout Treatment: Comparing Allopurinol, Benzbromarone, and Febuxostat in Patients with Gout in Remission

Spinal muscular atrophy

Study of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History

Osteoarthritis

Study on Improving Knee Implant Stability in Osteoarthritis Patients Using Denosumab and Zoledronic Acid

Duchenne muscular dystrophy

Study on the Effects of Fordadistrogene Movaparvovec for Patients with Duchenne Muscular Dystrophy

Rheumatoid arthritis

Study on the Long-Term Safety and Effectiveness of Filgotinib for Patients with Rheumatoid Arthritis

Psoriatic arthropathy

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

Glycogen storage disease type II

Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease

Myasthenia gravis

Study on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.